Physician profile
Arthur Celestin
NPI 1043574288
$6,246.40
in general payments reported to CMS, 2019-2025
18 companies · $98.68 in 2025
The $98.68 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2021: $2,549 · 2022: $1,854 · 2023: $251 · 2024: $1,386 · 2025: $98.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,424 · Travel and Lodging: $312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,424.30 |
| Travel and Lodging | $311.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trimed, INC. | $1,293.95 | 2024 | |
| Kairos Surgical INC | $1,225.63 | 2021 | |
| Suvon Surgical LLC | $1,200.00 | 2022 | |
| Sientra, INC. | $696.52 | 2021-2022 | |
| Mentor Worldwide LLC | $322.88 | 2019-2021 | |
| Tela Bio, INC. | $302.72 | 2021-2022 | |
| Allergan, INC. | $236.23 | 2021 | |
| Innovation Technologies INC | $213.84 | 2021 | |
| Axogen | $186.92 | 2022 | |
| Depuy Synthes Sales INC. | $144.60 | 2023 | Lcp |
| Vioptix INC | $125.72 | 2022 | |
| Acumed LLC | $66.17 | 2023 | Acumed |
| Abbvie INC. | $65.89 | 2024-2025 | |
| Medical Device Business Services, INC. | $53.64 | 2023-2024 | Va-Lcp, Matrixcombo |
| Integra Lifesciences Corporation | $41.18 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urgo Medical North America, LLC | $25.59 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Lifenet Health | $24.64 | 2024 | Theragenesis Wound Matrix |
| Sanara Medtech INC. | $20.28 | 2025 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Celestin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.